Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|236|4|407-420

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.4, 2015-08, pp. : 407-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autocrine Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for the Cyclooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 204-211

Karger

Access to resources Recommend Favorite

Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase‐2 and vascular endothelial growth factor expression

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 458-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease

By  

Journal of Vascular Research, Vol. 54, Iss. 1, 2017-01 ,pp. : 22-32

Karger

Access to resources Recommend Favorite

The Angiogenic Switch for Vascular Endothelial Growth Factor-A and Cyclooxygenase-2 in Prostate Carcinoma: Correlation with Microvessel Density, Androgen Receptor Content and Gleason Grade

By  

Urologia Internationalis, Vol. 87, Iss. 4, 2011-09 ,pp. : 464-469

Karger

Access to resources Recommend Favorite

A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-06 ,pp. : 317-320

Karger

Access to resources Recommend Favorite